NCT05221892View on ClinicalTrials.gov

Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo

PHASE4CompletedINTERVENTIONAL

Enrollment

334

Participants

Timeline

Start Date

November 22, 2021

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions

Vertigo

Interventions

DRUG

Gamma-aminobutyric acid tartarate, glutamic acid, dibasic calcium phosphate, thiamine nitrate, pyridoxine chloride and cyanocobalamin

Tablets to be taken 30 minutes before each of 4 trips.

DRUG

Ginger

Tablets to be taken 30 minutes before each of 4 trips.

Trial Locations (1)

25964004

Centro Universitário Serra dos Órgãos - UNIFESO, Teresópolis

All Listed Sponsors

lead

Fundação Educacional Serra dos Órgãos

OTHER

NCT05221892 - Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo | Biotech Hunter | Biotech Hunter